Kates M, Mansour AM, Lamm DL, et al. Phase 1/2 trial results of a large surface area microparticle docetaxel for the treatment of high-risk nonmuscle-invasive bladder cancer. J Urol. 2022 Oct;208(4):821-829. doi:10.1097/JU.0000000000002778
Local injection of docetaxel shows p... - Advanced Prostate...
Local injection of docetaxel shows promise for bladder cancer. Maybe it could be used for PCa where systematic therapy was not tolerated.
Written by
Graham49
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Interesting idea.
But only to supplement systemic therapy
By the time you get to docetaxel, you really don't know where the cancer is, even after a scan that will only find larger tumors.